Evidence map›Paper›PMID 40760352›Full record

ArticleCurrent microbiology2025

Quorum-sensing Inhibitory Activity of Xanthones from Hypericum Curvisepalum N. Robson Against Chromobacterium Violaceum.

Hong Zeng, Qiu-Ying He, Sheng-Qiang Yang, Xiao-Lian Wei, Jia-Zi Luo, Jing-Kai Zhou, Rong-Bing Fu, Li-Ping Teng, Zhong-Bo Zhou

Abstract read
PubMed Publisher
In one paragraph

Article in Current microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Hong Zeng *Guangxi Technology Innovation Cooperation Base of Prevention and Control Pathogenic Microbes with Drug Resistance, Youjiang Medical University for Nationalities, Baise, 533000, People's Republic of China.
Qiu-Ying He *Guangxi Technology Innovation Cooperation Base of Prevention and Control Pathogenic Microbes with Drug Resistance, Youjiang Medical University for Nationalities, Baise, 533000, People's Republic of China.
Sheng-Qiang YangGuangxi Technology Innovation Cooperation Base of Prevention and Control Pathogenic Microbes with Drug Resistance, Youjiang Medical University for Nationalities, Baise, 533000, People's Republic of China.
Xiao-Lian WeiGuangxi Technology Innovation Cooperation Base of Prevention and Control Pathogenic Microbes with Drug Resistance, Youjiang Medical University for Nationalities, Baise, 533000, People's Republic of China.
Jia-Zi LuoGuangxi Technology Innovation Cooperation Base of Prevention and Control Pathogenic Microbes with Drug Resistance, Youjiang Medical University for Nationalities, Baise, 533000, People's Republic of China.
Jing-Kai ZhouSchool of Pharmacy, Youjiang Medical University for Nationalities, 98 Chengxiang Road, Baise, 533000, People's Republic of China.
Rong-Bing FuSchool of Pharmacy, Youjiang Medical University for Nationalities, 98 Chengxiang Road, Baise, 533000, People's Republic of China.
Li-Ping TengGuangxi Technology Innovation Cooperation Base of Prevention and Control Pathogenic Microbes with Drug Resistance, Youjiang Medical University for Nationalities, Baise, 533000, People's Republic of China. tengliping2005@163.com.
Zhong-Bo ZhouGuangxi Technology Innovation Cooperation Base of Prevention and Control Pathogenic Microbes with Drug Resistance, Youjiang Medical University for Nationalities, Baise, 533000, People's Republic of China. zzb7855@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In recent years, bacterial drug resistance has increased alarmingly. The scarcity of novel antibiotics and few available drug targets significantly contribute to rising drug resistance. Searching quorum-sensing interfering agents and biofilm formation inhibitors are the most promising approaches for fighting multi-drug resistant bacterial infections. Chinese herbal medicines represent a rich repository for discovering quorum sensing (QS) inhibitors. In a continuation of the search for QS inhibitors from plants of Hypericum, significant bioactivity was observed in the ethyl acetate extract of Hypericum curvisepalum. Twelve known xanthones were obtained from this extract through bioassay-guided fractionation and subsequent identification (1-12), together with an undescribed analogue (16), two chromone derivatives (13 and 14), and a flavonoid (15). Compounds 2, 3, 6, and 7 showed apparent anti-quorum sensing activity against Chromobacterium violaceum ATCC12472 with violacein inhibition rates of 91.2, 90.6, 88.3, and 83.0% at 250 μM. In addition, compounds 2, 3, 6, and 7 also suppressed the motility and significantly reduced the biofilm formation of C. violaceum ATCC12472. Molecular docking analyses, Isothermal titration calorimetry (ITC) and qRT-PCR experiments suggested that these four compounds could bind with CviR receptor and downregulated genes vioB, vioC, and vioD encoding to regulate violacein biosynthesis. Xanthones from Hypericum could be considered as an important source of natural QS inhibitors towards C. violaceum ATCC12472.

Indexed as

Anti-Bacterial AgentsChromobacteriumHypericumQuorum SensingXanthonesBacterial ProteinsBiofilmsGene Expression Regulation, BacterialMicrobial Sensitivity TestsMolecular Docking SimulationPlant ExtractsAnti-Bacterial AgentsBacterial ProteinsPlant ExtractsXanthones

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.